Zhongshan Ophthalmic Center
Guangzhou, Guangdong, 510000, China
NCT Number: NCT05446077
To quantitatively analyze the fundus structure and microvascular characteristics of GFCS and non-GFCS (NGFCS) using optical coherence tomography angiography (OCTA), to explore the vascular-structural association, and to assess the diagnostic abilities of structure parameters.
Looking for future studies?
Notify Me4 year–18 year
All sexes
Observational
Guangzhou, Guangdong, 510000, China
A cross-sectional study. A total of 129 congenital cataract patients after congenital cataract extraction (40 in GFCS and 89 in NGFCS) were enrolled in this study from December 2020 to March 2021. All participants, age range from 4 to 18 years old, completed OCT examinations (including macular structure parameters, optic nerve fiber layer thickness periphery retinal nerve fiber layer [pRNFL], and sub foveal choroidal thickness [SFCT]). All the NGFCS participants underwent OCTA examinations (including vessel density (VD) and perfusion density (PD) of macular and peripapillary area.). Linear regression models were used to examine the effect of various factors on different ocular parameters. Vascular-structural associations were assessed with Spearman correlation. Diagnostic ability was evaluated with area under the receiver operating curve (AUC).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
NGFCS Group Inclusion Criteria:
GFCS Group Inclusion Criteria:
The diagnostic criteria of GFCS: Childhood: based on national criteria, <18 years old (USA); 16 years old (UK, Europe,UNICEF) Childhood glaucoma: two or more of the following are required
Time frame: December 1st 2020 to March 31st 2021
All participants completed OCT examinations (including macular structure parameters, optic nerve fiber layer thickness periphery retinal nerve fiber layer [pRNFL], and sub foveal choroidal thickness [SFCT]). All the NGFCS participants underwent OCTA examinations (including vessel density (VD) and perfusion density (PD) of macular and peripapillary area.). Linear regression models were used to examine the effect of various factors on different ocular parameters with demographic factors.
Time frame: December 1st 2020 to March 31st 2021
All participants completed OCT examinations (including macular structure parameters, optic nerve fiber layer thickness periphery retinal nerve fiber layer [pRNFL], and sub foveal choroidal thickness [SFCT]). All the NGFCS participants underwent OCTA examinations (including vessel density (VD) and perfusion density (PD) of macular and peripapillary area.). Vascular-structural associations were assessed with Spearman correlation.
Time frame: December 1st 2020 to March 31st 2021
All participants completed OCT examinations (including macular structure parameters, optic nerve fiber layer thickness periphery retinal nerve fiber layer [pRNFL], and sub foveal choroidal thickness [SFCT]). All the NGFCS participants underwent OCTA examinations (including vessel density (VD) and perfusion density (PD) of macular and peripapillary area.). Diagnostic ability of GFCS was evaluated with area under the receiver operating curve (AUC).
Sun Yat-sen University
Other
Quantitatively Analysis of Fundus Structure Characteristics in Glaucoma Following Congenital Cataract Surgery (GFCS) Using Optical Coherence Tomography Angiography
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05451745
Congenital Cataract, Glaucoma Following Pediatric Cataract Surgery
View Trial DetailsNCT04602923
Eye Diseases, Glaucoma
Montreal, Quebec, Canada
View Trial DetailsNCT03187418
Eye Diseases, Glaucoma
Montreal, Quebec, Canada
View Trial DetailsNCT04215575
Eye Diseases, Glaucoma
View Trial Details